Entropy Technologies LP Decreases Stock Position in Zoetis Inc. $ZTS

Entropy Technologies LP trimmed its position in shares of Zoetis Inc. (NYSE:ZTS) by 13.2% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 32,304 shares of the company’s stock after selling 4,902 shares during the quarter. Entropy Technologies LP’s holdings in Zoetis were worth $5,038,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Brighton Jones LLC raised its position in Zoetis by 180.4% in the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock worth $754,000 after purchasing an additional 2,978 shares during the period. PFG Advisors raised its holdings in shares of Zoetis by 28.9% in the first quarter. PFG Advisors now owns 9,627 shares of the company’s stock worth $1,585,000 after buying an additional 2,157 shares during the period. SYM FINANCIAL Corp bought a new stake in shares of Zoetis during the 1st quarter worth approximately $217,000. Wedbush Securities Inc. boosted its holdings in Zoetis by 91.0% during the 1st quarter. Wedbush Securities Inc. now owns 8,173 shares of the company’s stock valued at $1,346,000 after acquiring an additional 3,895 shares during the period. Finally, Pinnacle Associates Ltd. boosted its holdings in Zoetis by 12.9% during the 1st quarter. Pinnacle Associates Ltd. now owns 21,435 shares of the company’s stock valued at $3,529,000 after acquiring an additional 2,446 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

ZTS has been the topic of a number of recent analyst reports. BTIG Research reduced their target price on Zoetis from $200.00 to $160.00 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Morgan Stanley reduced their price target on shares of Zoetis from $211.00 to $175.00 and set an “overweight” rating on the stock in a research note on Monday, November 10th. Argus reissued a “buy” rating and issued a $190.00 price objective on shares of Zoetis in a research report on Tuesday, September 9th. Weiss Ratings restated a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday, October 8th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 5th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $178.89.

Zoetis Stock Down 1.0%

Shares of Zoetis stock opened at $115.86 on Friday. Zoetis Inc. has a 1 year low of $115.25 and a 1 year high of $181.85. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. The stock has a market cap of $51.06 billion, a price-to-earnings ratio of 19.94, a PEG ratio of 2.31 and a beta of 0.90. The firm’s 50-day moving average is $138.28 and its two-hundred day moving average is $150.42.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The firm had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.42 billion. During the same quarter in the prior year, the company earned $1.58 EPS. The company’s revenue was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, research analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis’s dividend payout ratio (DPR) is 33.67%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.